Source: Annual Congress 2012 - Asthma management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Duru, G. Yuce, A. Kelesoglu, T. Kaplan, M. Erdem, E. Agca, M. Kizilgün, F. Kara, S. Ardiç (Ankara, Turkey). The relationship between the serum YKL-40 level and severity of asthma. Eur Respir J 2012; 40: Suppl. 56, 3431

Member's Comments

No comment yet.

Related content which might interest you: The relationship between the severity of childhood asthma and leptin levels Source: Annual Congress 2007 - Risk factors for childhood asthma: cohort studies Year: 2007 Characterisation of asthma subgroups associated with circulating YKL-40 levels Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017 Year: 2017 Is serum leptin level a predictor for asthma? Source: Eur Respir J 2005; 26: Suppl. 49, 681s Year: 2005 Is there a relationship between severity of COPD and C-reactive protein (CRP) levels? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006 High serum levels of YKL-40 in IPF Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 The serum YKL-40 is a useful biomarker for asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors Year: 2011 Total serum bilirubin levels are not related to the severity of COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Comparable serum periostin levels among a Japanese population with asthma, COPD, and asthma-COPD overlap Source: International Congress 2017 – Many faces of asthma assessment Year: 2017 YKL-40 protein as a marker of asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 The study on the association of serum C-reactive protein level with the risk of lung cancer Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009 The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005 Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Relationship between blood eosinophil levels and severity of COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 The role of Hs-CRP in evaluating asthma severity and asthma control Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017